Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Eric Vicaut

Isabelle Mahé: Preventing Recurrent VTE in Cancer - What Does APICAT Show?
Oct 24, 2026, 09:30 | Science
Isabelle Mahé: Preventing Recurrent VTE in Cancer - What Does APICAT Show?
Isabelle Mahé, Head of Internal Medicine at the Louis Mourier Hospital, APHP at Paris Cité…
Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
Jul 8, 2026, 05:39 | Science
Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
Daniel Victor Ortigoza, Vice Chair of the Argentine Federation of Cardiology's Cardio-Oncology Committee, shared on…
Abdul Mannan: What Is the Most Common “Freeloading” Medication Seen in Anticoagulated Patients?
Jun 5, 2026, 01:54 | Voices
Abdul Mannan: What Is the Most Common “Freeloading” Medication Seen in Anticoagulated Patients?
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn…
Mital Jhaveri: Do Heart Failure Patients on Anticoagulants Still Need Aspirin?
May 21, 2026, 12:38 | Science
Mital Jhaveri: Do Heart Failure Patients on Anticoagulants Still Need Aspirin?
Mital Jhaveri, Clinical Anticoagulation, Heart Failure Pharmacist at NYC HHC Queens Hospital Center, shared a…
Isabelle Mahé: Bleeding Risk Differs Across Solid Tumours in Cancer-Associated Thrombosis
Mar 14, 2026, 13:44 | Science
Isabelle Mahé: Bleeding Risk Differs Across Solid Tumours in Cancer-Associated Thrombosis
Isabelle Mahé, Head of Internal Medicine at the Louis Mourier Hospital, APHP at Paris Cité…
Isabelle Mahé: Reduced-Dose Apixaban Lowers Bleeding Risk in CAT Without Losing Efficacy
Mar 8, 2026, 07:17 | Science
Isabelle Mahé: Reduced-Dose Apixaban Lowers Bleeding Risk in CAT Without Losing Efficacy
Isabelle Mahé, Head of Internal Medicine at the Louis Mourier Hospital, APHP at Paris Cité…
Isabelle Mahé: Cancer Site, Bleeding Risk, and Reduced-Dose Apixaban in Cancer-Associated Thrombosis
Mar 7, 2026, 15:05 | Science
Isabelle Mahé: Cancer Site, Bleeding Risk, and Reduced-Dose Apixaban in Cancer-Associated Thrombosis
Isabelle Mahé, Head of Internal Medicine at Louis Mourier Hospital, APHP at Paris Cité University,…
Babak Alex Vakili: Net Clinical Benefit Favors OAC Alone, According to the AQUATIC Trial
Nov 7, 2025, 01:34 | Insight
Babak Alex Vakili: Net Clinical Benefit Favors OAC Alone, According to the AQUATIC Trial
Babak Alex Vakili, President and CEO at Heart Vein and Vascular Clinic, shared on LinkedIn:…
NEJM Study: Aspirin with Oral Anticoagulation Raises Risks in Chronic Coronary Syndrome
Aug 31, 2025, 10:55 | Science
NEJM Study: Aspirin with Oral Anticoagulation Raises Risks in Chronic Coronary Syndrome
Ahmed Bennis, Professor of Cardiology at Ibn Rochd University Hospital, shared a post on X: ”Aspirin in Patients…
NEJM Publishes BRIDGE-TNK Trial: IV Tenecteplase Before Thrombectomy in Acute Ischemic Stroke
Jul 14, 2025, 12:22 | Insight
NEJM Publishes BRIDGE-TNK Trial: IV Tenecteplase Before Thrombectomy in Acute Ischemic Stroke
The New England Journal of Medicine (NEJM), has shared a post on X: “Original Article:…
All: 10 Posts: 1 - 100
NewsFeed